President Trump's Extensive Stock Trades Raise Ethical Concerns
President Donald Trump's recent financial disclosures reveal over 3,600 stock trades in early 2026, prompting scrutiny over potential conflicts of interest.
Recent financial disclosures reveal that President Donald Trump engaged in over 3,600 stock trades during the first quarter of 2026, with transactions totaling between $220 million and $750 million. These trades encompassed major technology and defense companies, including Nvidia, Oracle, Microsoft, Boeing, and Eli Lilly.
The Office of Government Ethics released two Form 278-T reports detailing these transactions, which occurred between January and March 2026. The filings do not specify who directed the trades, noting that the president's assets are managed by his children through a trust. A White House spokesperson stated, "There are no conflicts of interest. President Trump only acts in the best interests of the American public."
Ethics watchdogs have raised concerns about potential conflicts of interest, given the overlap between the president's investments and his administration's policies. For instance, trades involving Eli Lilly coincided with federal initiatives benefiting the company's weight-loss drugs. Additionally, President Trump was fined $200 for missing the 45-day deadline to disclose certain trades, including significant transactions involving Microsoft and Amazon.
This level of trading activity is unprecedented among modern U.S. presidents, who have typically used blind trusts or invested in broad-based mutual funds to avoid potential conflicts. The revelations have prompted calls for stricter regulations on stock trading by public officials to maintain public trust.